
Brilcure 90mg Tablet
Marketer
Indizen Pharmaceutical
Salt Composition
Ticagrelor (90mg)
Overview Brilcure 90mg Tablet
CardioGuard 90mg tablets are antiplatelet agents, preventing blood clot formation within blood vessels. This action helps avert heart attacks and strokes in individuals with pre-existing cardiac conditions. CardioGuard 90mg is also indicated for patients recovering from a recent heart attack, experiencing unstable angina, or post-stent placement. It mitigates the risk of further cardiac events, including recurrent heart attacks, stroke, or stent thrombosis. Concomitant use with aspirin, another antiplatelet medication, is typically prescribed. CardioGuard 90mg can be ingested with or without food, consistently at the same time daily; continuous use is crucial, even during asymptomatic periods. Cessation may elevate the risk of recurrent cardiovascular incidents. The most frequent adverse effect is increased bleeding tendency; injuries may bleed more profusely and for longer durations, though generally mild and self-resolving. Mild dyspnea may occur, usually resolving with continued therapy. Report persistent bleeding, worsening or persistent shortness of breath to your physician. CardioGuard 90mg is contraindicated in patients with active internal bleeding (e.g., ulcers, intracranial hemorrhage) or liver disease. Disclose any such conditions prior to commencing treatment.
Primary Ingredients of Brilcure 90mg Tablet
No text was provided to rewrite.
Uses of Brilcure 90mg Tablet
Reducing the risk of cardiovascular events
Major Benefits of Brilcure 90mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Brilcure 90mg tablets can be consumed with or without food; however, consistent daily timing is recommended.
Common Side effects of Brilcure 90mg Tablet:
- Bleeding
- Breathlessness
How to use Brilcure 90mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Brilcure 90mg Tablets can be consumed with or without food; however, consistent daily timing is recommended.
How Brilcure 90mg Tablet works:
CardioGuard 90mg tablets inhibit platelet aggregation, thus reducing the risk of dangerous thrombus formation and consequently minimizing the likelihood of stroke or myocardial infarction.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Brilcure 90mg Tablet with alcohol. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Brilcure 90mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of 90mg Brilcure Tablets with breastfeeding are lacking. Seek medical advice.
DrivingSAFE
Driving ability is typically unaffected by Brilcure 90mg Tablets.
KidneySAFE IF PRESCRIBED
The 90mg Brilcure tablet is considered safe for use by individuals with kidney impairment; no dosage modification is advised. Data regarding Brilcure 90mg tablet use in patients undergoing renal dialysis is currently limited.
LiverCAUTION
Patients with liver impairment should use Brilcure 90mg Tablets cautiously, potentially requiring dose modification under medical supervision. Brilcure 90mg Tablets are contraindicated for those with severe hepatic dysfunction.
What if you forget to take Brilcure 90mg Tablet :
Should you forget a Brilcure 90mg Tablet dose, take it immediately. But, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Brilcure 90mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Triazolo[1,5-a]pyrimidines |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | ADP receptor antagonists (P2Y12 inhibitors) |
